Table 8.
Relationships of Biomarkers with LVH-ht1.7, iLVH and E/e’ >14 as Based on ROC Curve Analysis in All and Dialysis Patients
| Relationship | n (%) | OR (95% CI) | p |
|---|---|---|---|
| All Patients (n=109) Ferritin >150 ng/mL versus LVH-ht1.7 | 57 (52.3%) | 2.85 (1.23–6.58) | 0.014 |
| Parathyroid hormone >199 pg/mL versus LVH-ht1.7 | 56 (51.4%) | 4.25 (1.72–10.50) | 0.002 |
| Gamma-glutamyl transferase >68 U/l versus E/e’ >14 | 25 (22.9%) | 5.42 (1.59–18.46) | 0.007 |
| Dialysis patients (n=45) | |||
| Ferritin >345 ng/mL versus LVH-ht1.7 | 23 (51.1%) | 5.00 (1.20–20.81) | 0.027 |
| Uric acid <0.28 mmol/l versus iLVH | 21 (46.7%) | 21.74 (3.30–143.1) | 0.001 |
| Albumin <36 g/l versus E/e’ >14 | 13 (28.9%) | 5.87 (1.06–32.2) | 0.040 |
Note: All relationships were adjusted for age, sex and race. Significant associations are shown in bold.
Abbreviations: ROC, receiver operator characteristic; OR, odds ratio; CI, confidence interval; LVH-ht1.7, left ventricular hypertrophy indexed to body height1.7; iLVH, inappropriate left ventricular hypertrophy.